Pharmacophore models for GABA_A modulators: implications in CNS drug discovery

Author： Ghoshal Nanda Vijayan R Suyambu Kesava

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.5, Iss.5, 2010-05, pp. : 441-460

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of Molecular Modeling Approaches to Pharmacophore Models and Structure-Activity Relationships of Ion Channel Modulators in CNS

Current Pharmaceutical Design, Vol. 8, Iss. 2, 2002-01 ,pp. : 99-110

Bentham Science Publishers

Access to resources Recommend Favorite

α-Subunit selective modulators of GABAA receptor function as CNS therapeutics

By Hamilton Niall M Cooke Andrew J

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 10, 2002-10 ,pp. : 1491-1501

Informa Healthcare

Access to resources Recommend Favorite

Pharmacophore Modeling in Drug Discovery and Development: An Overview

Medicinal Chemistry, Vol. 3, Iss. 2, 2007-03 ,pp. : 187-197

Bentham Science Publishers

Access to resources Recommend Favorite

An overview of CNS drug discovery at Eli Lilly and Company

By Paul S.M.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 254-254

Elsevier

Access to resources Recommend Favorite

Modeling of PET data in CNS drug discovery and development

By Varnäs Katarina

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 40, Iss. 3, 2013-06 ,pp. : 267-279

Springer Publishing Company

Access to resources Recommend Favorite